Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GHK-Cu's Unique Regulatory Situation What makes GHK-Cu's regulatory story unique is its dual classification based on route of administration: What This Means Non-injectable GHK-Cu (topical creams, serums, etc.) was in Category 1 meaning it was under evaluation but generally available for compounding
Additional discussions, including comparisons with FDA drug labels and major clinical guidelines, are presented in Supplementary Materials 4
Appetitregulation Ein zentrales Ziel ist die Dmpfung des Hungergefhls
The documentation your insurer typically wants includes a recorded BMI meeting the threshold (30 or above, or 27 with comorbidities), proof of at least one qualifying comorbidity, evidence of previous weight loss attempts (usually 3-6 months of documented lifestyle intervention), current lab work showing relevant metabolic markers, and a letter of medical necessity from your prescribing physician
Key Findings from Phase 2 Trials and the Phase 3 Programme Phase 2 data showed approximately 24% mean body weight reduction at the highest dose over 48 weeks
US$ 25.79
US$ 29.38
US$ 20.54
US$ 24.96
